Turning on repair mechanisms in cells that survive injury in the heart and other tissues
In mammals, including humans, the cells that contract the heart muscle and enable it to beat do not regenerate after injury. After a heart attack, there is a dramatic loss of these heart muscle cells and those that survive cannot effectively replicate. With fewer of these contractile cells, known as cardiomyocytes, the heart pumps less blood with each beat, leading to the increased mortality associated with heart disease.
Now, researchers at the University of Pennsylvania’s School of Engineering and Applied Science and Perelman School of Medicine have used mouse models to demonstrate a new approach to restart replication in existing cardiomyocytes: an injectable gel that slowly releases short gene sequences known as microRNAs into the heart muscle.
Though the reasons cardiomyocytes don’t regenerate aren’t fully understood, the researchers used microRNAs that target signaling pathways related to cell proliferation, and were able to inhibit some of the inherent “stop” signals that keep cardiomyocytes from replicating. This resulted in cardiomyocytes reactivating their proliferative potential.
With more heart cells dividing and reproducing, mice treated with this gel after heart attack showed improved recovery in key clinically relevant categories.
The study was led by Edward Morrisey, Professor in Medicine, member of the Cell and Molecular Biology graduate group and Scientific Director of the Penn Institute for Regenerative Medicine in Penn Medicine; Jason Burdick, Professor in Bioengineering in Penn Engineering; Leo Wang, a graduate student in Burdick’s lab; and Ying Liu, a postdoctoral researcher in Morrisey’s lab.
It was published in the journal Nature Biomedical Engineering.
MicroRNA-based therapies have been studied in the past, but delivering the right dose to the right place has been a consistent challenge.
“Biologic drugs turn over very fast,” Morrisey said. “The microRNAs that we used last less than eight hours in the bloodstream, so having a high local concentration has strong advantages.”
Their short lifespan means that if patients were treated systemically, they would need to be injected frequently with large doses to ensure that a sufficient amount of microRNAs reaches their target in the heart. And because these microRNAs are designed to promote cell proliferation, there would be a risk of tumor-producing, off-target effects.
The Morissey lab studies signaling pathways involved in heart and lung development and regeneration, while the Burdick lab has experience in designing biocompatible materials for drug delivery. The two groups collaborated to find the best way to get the microRNAs to the cardiomyocytes and have them persist long enough to be effective.
“We want to design the right material for a specific drug and application,” Burdick said. “The most important traits of this gel are that it’s shear-thinning and self-healing. Shear-thinning means it has bonds that can be broken under mechanical stress, making it more fluid and allowing it to flow through a syringe or catheter. Self-healing means that when that stress is removed, the gel’s bonds re-form, allowing it to stay in place within the heart muscle.”
“In addition to the bonds that give the gel its consistency,” Wang said, “the gel features attachment sites that keep the microRNAs in place. As the gel breaks down, it loses its grip on the microRNAs, which can slip out of the gel and into the cardiomyocytes.”
While encapsulated, the microRNAs are also protected from degradation, maximizing the time period that they can be effective without the risk of them invading off-target cells.
“There’s likely a time window that the cardiomyocytes are susceptible to this stimulus —maybe a week or two after injury,” Morrisey said. “We want to promote proliferation for a short period and then stop.”
To test their gel, the researchers used three types of mouse models.
The first group was normal, healthy mice. Within a few days after injecting the gel, their heart tissue showed increased biomarkers of cardiomyocyte proliferation.
The second group was “Confetti mice,” so called because they are genetically engineered such that they have individual cardiomyocytes that randomly express one of four different fluorescent proteins. These fluorescent labels allowed the researchers to see that individual cardiomyocytes were indeed dividing in response to the microRNA- gel treatment. After inducing heart attacks in the mice and introducing the microRNA-gel, the researchers could see that single red, yellow or green cardiomyocytes had become clusters, ranging from two to eight cells of the same color.
The third group was mice in which heart attacks were also induced so that clinically relevant outcomes of the treatment could be studied. These mice showed improved recovery as compared to controls, including higher ejection fraction — more blood pumped with each beat — and smaller increases in heart size. Enlarged hearts are a common consequence of heart attacks, with the expanded area composed of non-contractile scar tissue.
With promising results in mice, next steps for the researchers will involve testing human heart cells in vitro and conducting physiological experiments in animals with more human-like hearts, such as pigs.
More than a potentially life-prolonging treatment itself, the researchers see this microRNA-gel approach as representing a new, more direct avenue for precision regenerative medicine.
“We’re seeing a change in approaches for regenerative medicine, using alternatives to stem cell delivery,” Burdick said. “Here, instead of introducing new cells that can have their own delivery challenges, we’re simply turning on repair mechanisms in cells that survive injury in the heart and other tissues.”
The Latest on: Turning on repair mechanisms in cells
- ‘Science is a contact sport’: What one U of T researcher learned in the lab of Nobel laureate William Kaelinon November 15, 2019 at 9:14 am
They showed that without a functional VHL protein, these complexes are unable to degrade another protein called hypoxia-inducible factor (HIF), which in turn spurs tumour cell survival and growth even ...
- Master regulator in mitochondria is critical for muscle function and repairon November 15, 2019 at 7:55 am
"This means that mitochondrial calcium uptake is important for normal repair of muscle, and this was not known before," says co-author Dr. Seifert, assistant professor in the department of pathology, ...
- Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migrationon November 15, 2019 at 2:18 am
A search for the underlying mechanism revealed ... Gsk3β that in turn causes destabilization of Snail and β-catenin, thus reverting epithelial to mesenchymal transition (EMT). However, alone aspirin ...
- Discovery reveals mechanism that turns herpes virus on and offon November 14, 2019 at 2:21 pm
New research has identified a new mechanism that plays a role in controlling ... which causes the virus to go dormant. But if the cells are unsuccessful, the chromatin is only loosely bundled, leaving ...
- Elevated Hedgehog activity contributes to attenuated DNA damage responses in aged hematopoietic cellson November 14, 2019 at 9:27 am
Burkhalter MD, Rudolph KL, Sperka T. Genome instability of ageing stem cells-Induction and defence mechanisms. Ageing Res Rev. 2015;23(Pt A):29–36. Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T ...
- Motorola Razr hands-on: Back in blackon November 13, 2019 at 9:59 pm
Motorola has constructed a special hinge mechanism to make the phone fold completely flat ... If you’re a fan of Moto actions, those are all present here. You can chop the phone to turn on the ...
- Children’s Hospital Los Angeles Uncovers a New Frontier in Heart Tissue Regeneration Researchon November 13, 2019 at 4:09 pm
Researchers discover a mechanism of heart repair in zebrafish that could change the field of heart research One of ... Their malfunction may cause fluid build-up or limited clearing of damaged cells ...
- Researchers reveal mechanisms that lead to onset of Type 1 diabeteson November 6, 2019 at 10:27 am
Researchers Lorenzo Pasquali and Mireia Ramos-Rodríguez have published recently in Nature Genetics the results of a study on the mechanisms that cause ... and control which genes are must turn on and ...
- Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver diseaseon November 4, 2019 at 8:18 am
The researchers, in collaboration with colleagues in the UK and Germany, explored the molecular mechanism that provides ductal cells with this power to regenerate the liver tissue. They showed that ...
- CHLA researcher receives NIH grant to study repair and regeneration mechanisms in the guton July 22, 2019 at 11:30 am
It's turning over constantly because it's always exposed to toxins and bacteria." This rapid turnover of cells is a mechanism ... regenerates to repair itself after injury. The new funding will help ...
via Google News and Bing News